Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Harte Hanks (HHS) Shares Outstanding (Weighted Average) (2016 - 2025)

Harte Hanks (HHS) has disclosed Shares Outstanding (Weighted Average) for 15 consecutive years, with $7.4 million as the latest value for Q2 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 1.57% to $7.4 million in Q2 2025 year-over-year; TTM through Jun 2025 was $7.4 million, a 1.57% increase, with the full-year FY2024 number at $7.3 million, changed 0.23% from a year prior.
  • Shares Outstanding (Weighted Average) was $7.4 million for Q2 2025 at Harte Hanks, up from $7.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $7.4 million in Q1 2023 to a low of $6.7 million in Q1 2021.
  • A 5-year average of $7.1 million and a median of $7.2 million in 2022 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): grew 7.11% in 2021, then dropped 1.83% in 2024.
  • Harte Hanks' Shares Outstanding (Weighted Average) stood at $6.8 million in 2021, then increased by 4.4% to $7.1 million in 2022, then increased by 2.94% to $7.3 million in 2023, then decreased by 0.23% to $7.3 million in 2024, then increased by 1.07% to $7.4 million in 2025.
  • Per Business Quant, the three most recent readings for HHS's Shares Outstanding (Weighted Average) are $7.4 million (Q2 2025), $7.3 million (Q4 2024), and $7.3 million (Q3 2024).